ImmunityBio News and Activities

Presence

ImmunityBio is a biotechnology company that develops cancer and immune disease treatments. It offers immunotherapy products and clinical research services for patients, healthcare providers, and medical institutions.

ImmunityBio products and services overview:

  • Cancer therapies
  • Immunotherapy products
  • Cell therapies
  • Clinical research

Revenue: ~$20 million

Employees: 800

Headquarters: Culver City, United States (USA)


ImmunityBio is one of the...

ImmunityBio is a company listed under the stock ticker IBRX (US).

Executives

View the org chart displaying its 39 main executives

Most searched biographies at ImmunityBio
Popular executive movements at ImmunityBio
  • Bruce Wendel has joined the company as Director  (posted on December 16 2025).

Create your alert
to follow the executive moves at ImmunityBio.

Biotechnology

ImmunityBio has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by ImmunityBio
Social media about ImmunityBio

Get in Touch

Call ImmunityBio at +1 415...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board